Celator Pharmaceuticals' Debt Round

Celator Pharmaceuticals raised a round of funding on May 14, 2010.

Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identif…

Articles about Celator Pharmaceuticals' Debt Round: